Screening Strategies to Improve Early Diagnosis in Endometrial Cancer
Journal of Clinical Medicine · 13.09.2024 · 13 (18) · 5445
DOI: 10.3390/jcm13185445 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 13.09.2024. Verfasst von Silvia Cabrera und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gynecologic Oncology Unit, Department of Gynecology and Obstetrics, Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Ministerio de Ciencia, Tecnología e Innovación, Departament de Recerca i Universitats.
Abstract (Originalsprache)
Endometrial cancer is the most common gynecological malignancy in high-income countries and the sixth most common cancer in women. Overall incidence has risen in the last few decades as a consequence of the increase in the prevalence of its risk factors, mainly obesity and the aging of the population, and although diagnoses have increased across all age groups, the incidence rates have doubled in women under the age of 40 years. The survival rates of endometrial cancer are highly dependent on its stage at diagnosis, bringing to the fore the importance of early diagnosis. The aim of a screening strategy in this type of tumor should be to detect the disease in the pre-invasive or early stage (before developing myometrial invasion), which would improve cure rates, reduce the morbidity associated with aggressive treatment and offer uterus-sparing management options for younger women. The ideal screening tool in this scenario would be a minimally invasive, inexpensive and easy-to-perform test or auto-test, which could be implemented in a routine gynecologic checkup of patients at-risk or in the general adult population. In this comprehensive review, we aim to define the populations at higher risk of developing endometrial cancer, to assess the performance of current diagnostic tools when used in a screening setting and to discuss the accuracy of new molecular screening strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gynecologic Oncology Unit, Department of Gynecology and Obstetrics, Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain.
- Fundación Santiago Dexeus Font, Gynecology, Obstetrics and Reproductive Medicine Department, Dexeus Mujer, 08028 Barcelona, Spain.
- Research Group in Gynecology, Vall d'Hebron Institut de Recerca, 08035 Barcelona, Spain.
ORCID-Profile: Silvia Cabrera, Antonio Gil-Moreno, Eva Colas
Förderung
- Instituto de Salud Carlos III
- Ministerio de Ciencia, Tecnología e Innovación
- Departament de Recerca i Universitats
- Centro de Investigación Biomédica en Red de Cáncer
- European Commission
- Ministerio de Ciencia, Innovación y Universidades through a Proyectos en Colaboración Publico-Privada 2021
- Generalitat de Catalunya
- CIBERONC
Zitieren
APA
Cabrera, S., de la Calle, I., Baulies, S., Gil-Moreno, A., & Colas, E. (2024). Screening Strategies to Improve Early Diagnosis in Endometrial Cancer. Journal of Clinical Medicine, 13(18), 5445. https://doi.org/10.3390/jcm13185445
Vancouver
Cabrera S, de la Calle I, Baulies S, Gil-Moreno A, Colas E. Screening Strategies to Improve Early Diagnosis in Endometrial Cancer. Journal of Clinical Medicine. 2024;13(18):5445. doi:10.3390/jcm13185445
BibTeX
@article{Cabrera2024,
author = {Cabrera, Silvia and de la Calle, Irene and Baulies, Sonia and Gil-Moreno, Antonio and Colas, Eva},
title = {Screening Strategies to Improve Early Diagnosis in Endometrial Cancer},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {18},
pages = {5445},
doi = {10.3390/jcm13185445}
}
EUVIMED